Presentation of a residual post-myocardial infarction ventricular septal defect; a literature review based on a case

Mehrdad Jafari1, Mohammad Khani1, Tooba Akbari1

  • 1Cardiovascular Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran.

Insights

Post-infarction ventricular septal defects (VSDs) are rare but can be fatal. This case highlights a delayed-presented VSD, emphasizing the need for vigilance and comprehensive imaging, especially in the COVID-19 era.

Area of Science:

  • Cardiology
  • Cardiovascular Surgery
  • Internal Medicine

Background:

  • Post-myocardial infarction ventricular septal defect (VSD) is a rare complication, often missed despite modern diagnostic and revascularization techniques.
  • The COVID-19 pandemic has been associated with an increased prevalence of VSDs following myocardial infarction.
  • This case highlights a delayed presentation of a post-infarction VSD, emphasizing the need for continued vigilance.

Purpose of the Study:

  • To present a case of a delayed-presented post-infarction ventricular septal defect (VSD).
  • To underscore the importance of comprehensive cardiac investigations in diagnosing potentially fatal VSDs.
  • To raise awareness of increased VSD prevalence in the COVID-19 era.

Main Methods:

  • A 58-year-old male presented with exertional dyspnea two months prior.
  • History of myocardial infarction complicated by VSD and hemodynamic instability, managed surgically three years prior.
  • Transthoracic echocardiogram revealed a residual VSD with a left-to-right shunt and myocardial aneurysm.

Main Results:

  • A residual ventricular septal defect (VSD) was identified in the area of a previously repaired patch.
  • The VSD presented with a left-to-right shunt and was associated with a myocardial aneurysm.
  • Follow-up echocardiogram after six months showed no changes.

Conclusions:

  • Post-infarction VSDs, though rare, require heightened clinical suspicion and comprehensive imaging for diagnosis.
  • The COVID-19 era has seen an increase in VSD prevalence, necessitating vigilance in affected patients.
  • Residual defects can manifest following initial management, underscoring the need for thorough cardiac assessments.
Abstract

Related Concept Videos

Mitral Valve Prolapse II: Assessment and Management01:22

Mitral Valve Prolapse II: Assessment and Management

IntroductionA range of clinical features characterizes Mitral Valve Prolapse (MVP), but it is important to note that many individuals with MVP are asymptomatic and may remain so throughout their lives. For those who do exhibit symptoms, the following are the key clinical features:Palpitations: This is a common symptom where individuals feel an irregular or rapid heartbeat. Palpitations in MVP are often due to arrhythmias such as premature ventricular contractions or supraventricular tachycardia.
Mitral Regurgitation I: Introduction01:20

Mitral Regurgitation I: Introduction

Mitral regurgitation is characterized by the backward circulation of blood from the left ventricle to the left atrium during systole, a phase of the cardiac cycle when the heart contracts and pumps blood out of the chambers. This abnormal flow occurs primarily due to the dysfunction of the mitral valve or its supporting structures, which include the mitral leaflets, chordae tendineae, annulus, and papillary muscles.Etiology and Mechanisms:Primary Mitral Regurgitation: This type arises from...
Mitral Regurgitation II: Clinical Features and Diagnostic Tests01:23

Mitral Regurgitation II: Clinical Features and Diagnostic Tests

Mitral regurgitation (MR) is a valvular heart disorder in which the mitral valve fails to close tightly, allowing blood to leak backward into the heart. Understanding the clinical manifestations, assessment, diagnostic findings, and medical management of MR is crucial to effectively managing affected patients.Clinical Manifestations of Mitral RegurgitationMitral regurgitation can be acute or chronic, each presenting differently and requiring different approaches:1. Acute Mitral...
Mitral Stenosis I: Introduction01:22

Mitral Stenosis I: Introduction

Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
Mitral Stenosis II: Clinical features and Diagnostic Tests01:23

Mitral Stenosis II: Clinical features and Diagnostic Tests

Mitral stenosis is a heart condition in which the mitral valve, which allows blood to flow from the left atrium to the left ventricle, becomes narrowed or stenotic. This narrowing hinders blood flow and leads to clinical symptoms requiring specific medical evaluations and management strategies. The following overview outlines the clinical symptoms, assessments, diagnostic findings, prevention methods, and treatments for mitral stenosis.Clinical ManifestationsDyspnea (shortness of breath): This...
Aortic Regurgitation I: Introduction01:15

Aortic Regurgitation I: Introduction

IntroductionAortic regurgitation is characterized by the backward flow of blood from the aorta into the left ventricle during diastole and arises from the improper closure of the aortic valve. This condition results in left ventricular volume overload and can stem from both acute and chronic etiologies, each contributing uniquely to the disease's progression and symptomatology.Acute and Chronic CausesAcute aortic regurgitation often results from events that suddenly impair the integrity of the...